Adenosine A2 receptors: selective localization in the human basal ganglia and alterations with disease
- PMID:1835521
- DOI: 10.1016/0306-4522(91)90038-p
Adenosine A2 receptors: selective localization in the human basal ganglia and alterations with disease
Abstract
Adenosine A2 receptors were labeled and visualized by autoradiography in tissue sections of the human brain using the A2-selective agonist ligand [3H](2-p-(2-carboxyethyl)phenylamino)-5'-N-carboxamidoadenosine (CGS 21680). The binding of this ligand was of high affinity, reversible, and was blocked by adenosine A2 agents. Autoradiographic mapping of adenosine A2 sites revealed them to be exclusively restricted to the caudate nucleus, putamen, nucleus accumbens, olfactory tubercle and the lateral segment of the globus pallidus. The densities of adenosine A2 receptors in other brain areas did not differ from background levels. This selective localization prompted us to study the consequences of neurodegenerative diseases such as Parkinson's disease and Huntington's chorea on the densities and localization of these sites in the basal ganglia. In Parkinson's disease the density of adenosine A2 binding sites was comparable to that seen in control cases. In contrast, density values of A2 sites were dramatically decreased, compared to control values, in the basal ganglia of patients with Huntington's chorea. Similar losses of A2 receptors were observed in the guinea-pig striatum after local application of quinolinic acid while lesioning of the dopaminergic neurons was without effect. All these results taken together suggest that adenosine A2 receptors are localized on striatal output neurons which degenerate in Huntington's chorea.
Similar articles
- Loss of striatal histamine H2 receptors in Huntington's chorea but not in Parkinson's disease: comparison with animal models.Martínez-Mir MI, Pollard H, Moreau J, Traiffort E, Ruat M, Schwartz JC, Palacios JM.Martínez-Mir MI, et al.Synapse. 1993 Nov;15(3):209-20. doi: 10.1002/syn.890150306.Synapse. 1993.PMID:7904088
- The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease.Glass M, Dragunow M, Faull RL.Glass M, et al.Neuroscience. 2000;97(3):505-19. doi: 10.1016/s0306-4522(00)00008-7.Neuroscience. 2000.PMID:10828533
- Mesostriatal and mesolimbic dopamine uptake binding sites are reduced in Parkinson's disease and progressive supranuclear palsy: a quantitative autoradiographic study using [3H]mazindol.Chinaglia G, Alvarez FJ, Probst A, Palacios JM.Chinaglia G, et al.Neuroscience. 1992 Jul;49(2):317-27. doi: 10.1016/0306-4522(92)90099-n.Neuroscience. 1992.PMID:1436470
- Insight Into the Emerging Role of Striatal Neurotransmitters in the Pathophysiology of Parkinson's Disease and Huntington's Disease: A Review.Jamwal S, Kumar P.Jamwal S, et al.Curr Neuropharmacol. 2019;17(2):165-175. doi: 10.2174/1570159X16666180302115032.Curr Neuropharmacol. 2019.PMID:29512464Free PMC article.Review.
- Chapter 33: the history of movement disorders.Lanska DJ.Lanska DJ.Handb Clin Neurol. 2010;95:501-46. doi: 10.1016/S0072-9752(08)02133-7.Handb Clin Neurol. 2010.PMID:19892136Review.
Cited by
- Adenosinergic mechanisms contribute to individual differences in sleep deprivation-induced changes in neurobehavioral function and brain rhythmic activity.Rétey JV, Adam M, Gottselig JM, Khatami R, Dürr R, Achermann P, Landolt HP.Rétey JV, et al.J Neurosci. 2006 Oct 11;26(41):10472-9. doi: 10.1523/JNEUROSCI.1538-06.2006.J Neurosci. 2006.PMID:17035531Free PMC article.Clinical Trial.
- Adenosine A2A receptors are up-regulated in Pick's disease frontal cortex.Albasanz JL, Rodríguez A, Ferrer I, Martín M.Albasanz JL, et al.Brain Pathol. 2006 Oct;16(4):249-55. doi: 10.1111/j.1750-3639.2006.00026.x.Brain Pathol. 2006.PMID:17107593Free PMC article.
- Adenosine A(2a) receptor antagonists: potential therapeutic and neuroprotective effects in Parkinson's disease.Morelli M, Wardas J.Morelli M, et al.Neurotox Res. 2001 Nov;3(6):545-56. doi: 10.1007/BF03033210.Neurotox Res. 2001.PMID:15111244
- Adenosine A2A Receptor Modulates the Activity of Globus Pallidus Neurons in Rats.Diao HL, Xue Y, Han XH, Wang SY, Liu C, Chen WF, Chen L.Diao HL, et al.Front Physiol. 2017 Nov 7;8:897. doi: 10.3389/fphys.2017.00897. eCollection 2017.Front Physiol. 2017.PMID:29163226Free PMC article.
- Effect of A2A adenosine receptor stimulation and antagonism on synaptic depression induced by in vitro ischaemia in rat hippocampal slices.Latini S, Bordoni F, Corradetti R, Pepeu G, Pedata F.Latini S, et al.Br J Pharmacol. 1999 Nov;128(5):1035-44. doi: 10.1038/sj.bjp.0702888.Br J Pharmacol. 1999.PMID:10556941Free PMC article.
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical